HFA Premium Access

Heart Failure Drug Titration, Discontinuation and Mortality and HF Hospitalization Risk: A Multinational Observational Study (US, UK and Sweden)

Topic: Epidemiology, Prognosis, Outcome

Congress Presentation

About the speaker

Professor Gianluigi Savarese

Karolinska Institute, Stockholm (Sweden)
64 presentations
13 followers

10 more presentations in this session

SCD and ventricular event rates in a Japanese population: Primary results from the Heart Failure Indication and Sudden Cardiac Death Prevention Trial

Speaker: Doctor K. Aonuma (Tsukuba, JP)

Thumbnail

Clinical course and related costs of patients with type 2 diabetes and heart failure and/or chronic kidney disease, drawn from a sample of more than 7 million people

Speaker: Professor A. Maggioni (Florence, IT)

Thumbnail

Potential Implications of Expanded FDA Labeling for Sacubitril/Valsartan in the United States

Speaker: Doctor M. Vaduganathan (Boston, US)

Thumbnail

Prescription Fill Patterns of Guideline-Directed Medical Therapies for Heart Failure During the COVID-19 Pandemic in the United States

Speaker: Doctor M. Vaduganathan (Boston, US)

Thumbnail

Higher Alkaline Phosphatase Mean and Variability Predict Heart Failure and All-cause Mortality

Speaker: Ms S. Lee (Shatin, HK)

Thumbnail

Access the full session

Registry Updates

Speakers: Professor G. Savarese, Doctor K. Aonuma, Professor A. Maggioni, Doctor M. Vaduganathan, Doctor M. Vaduganathan...
Thumbnail

About the event

Image

Heart Failure 2021

29 June - 1 July 2021

Sessions Presentations